PCSK9 Inhibitors for Severe COVID? Pilot Trial Signals of Benefit

RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial

A Novel Mechanism May Be Effective in Patients With Severe Hypertriglyceridemia and Prior Episodes of Acute Pancreatitis

RNA Inhibitor Shows Early Efficacy, Safety in Adults With Mixed Dyslipidemia

Despite recommendations, statin use ‘not ubiquitous’ in CKD with ASCVD

High Blood Viscosity May Predict Mortality In COVID-19 Hospitalization

Prestigious Award Named in Honor of Valentin Fuster, MD, PhD, During American College of Cardiology Scientific Session

Study Shows a Significant Reduction in Triglycerides in Patients at High Risk for Acute Pancreatitis Through a Novel Monoclonal Antibody

A Novel Monoclonal Antibody Therapy Cuts LDL Cholesterol by Half in a High-Risk Patient Population, Study Shows

"Guideline-based Statin Use, Adherence Higher with Cardiologist Care" - Scott Buzby

"CV Risk Rises When Payers Deny Alirocumab, Evolocumab Coverage" - Megan Brooks